News
Owlstone Medical Enters into a Research Collaboration Agreement with the FDA to Support the Confident Identification of Volatile Organic Compounds on Breath and Expansion of its Breath Biopsy VOC Atlas®
30 Sep 2024
Read More
Owlstone Medical to Contribute Breath Biopsy to 3TR, the Largest-ever IMI2 Immunology Project to Improve Disease Management Across Seven Immune-Mediated Diseases
Read More
29 Oct 2019
Cleveland Clinic Partners with Owlstone Medical to Establish New Center
Read More
15 Oct 2019
Owlstone Medical Announces Advancements in Breath Biopsy Platform Including Launch of Next Generation ReCIVA Breath Sampler and CASPER Portable Air Supply
Read More
15 Sep 2019
Owlstone Medical Announces a Novel Approach to Breath-Based Testing for Investigation of the Onset, Progression, and Treatment of Disease
Read More
18 Jun 2019
Owlstone Medical and the International Association of Heat and Frost Insulators and Allied Workers Partner to Identify Breath Biomarkers for the Early Detection of Malignant Mesothelioma
Read More
5 Jun 2019
Owlstone Medical Enters into a Strategic Collaboration with Actelion to Develop a Breath-Based Test to Help Facilitate Early Detection of Pulmonary Hypertension
Read More
20 May 2019
University of Manchester and Owlstone Medical Partner on £250,000 Grant from Asthma UK and Innovate UK for Asthma Diagnostic Development
Read More
7 Mar 2019
Owlstone Medical Partners with Shanghai Renji Hospital to Pioneer Breath Biopsy Lung Cancer Trial in China
Read More
20 Feb 2019
Clinical Trial Launches to Develop Breath Test for Multiple Cancers
Read More
3 Jan 2019
Owlstone Medical Named in Top 10 Disruptors to Watch by Sunday Times
Read More
3 Dec 2018
Owlstone Medical Appoints Dr Richard A Yost to Scientific Advisory Board
Read More
10 Oct 2018
Owlstone Medical Completes $50 Million USD (c.£38 Million GBP) Financing Round
Read More
7 Oct 2018